422
Participants
Start Date
November 30, 2004
Primary Completion Date
April 30, 2006
Study Completion Date
April 30, 2006
BAY86-5016, SH P00331F
Drug amount per patch: 0.9 mg EE2 + 1.9 mg gestodene (GSD)
SH P00331N
Drug amount per patch: 0.6 mg EE2 + 6 mg NGM
Vienna
Vienna
Wörgl
Bregenz
Graz
Zeltweg
San Fernando
Santiago de Compostela
Salt
Guadalajara
Turku
Turku
Toulouse
Bordeaux
Pontevedra
Roanne
Montargis
Nancy
Compiègne
Compiègne
Biarritz
Paris
Saint-Germain-en-Laye
Maisons Lafitte
Pantin
Helsinki
Helsinki
Barcelona
Lead Sponsor
Bayer
INDUSTRY